Evidence map›Paper›PMID 21493000›Full record

ArticleCancer letters2011

Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis.

Ashish K Tiwari, Susan E Crawford, Andrew Radosevich, Ramesh K Wali, Yolanda Stypula, Dhananjay P Kunte, Nikhil Mutyal, Sarah Ruderman, Andrew Gomes, Mona L Cornwell and 5 more

Abstract read
In one paragraph

Article in Cancer letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. World journal of gastrointestinal endoscopy · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Colonic mucosal fatty acid synthase as an early biomarker for colorectal neoplasia: modulation by obesity and gender.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  14. Article
  15. Article
  16. Hemoglobin parameters from diffuse reflectance data.Journal of biomedical optics · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ashish K TiwariDepartment of Medicine, NorthShore University HealthSystem, Evanston, IL, USA.
Susan E Crawford
Andrew Radosevich
Ramesh K Wali
Yolanda Stypula
Dhananjay P Kunte
Nikhil Mutyal
Sarah Ruderman
Andrew Gomes
Mona L Cornwell
Mart De La Cruz
Jeffrey Brasky
Tina P Gibson
Vadim Backman
Hemant K Roy
NorthShore University HealthSystem · USNorthwestern University · US

Funding

Novel Biophotonics Methodology for Colon Cancer ScreeningR01CA128641 · NCI · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM · 2008 to 2012
$7.3M
Spectral Markers for Early Detection of Colon NeoplasiaU01CA111257 · NCI · NORTHSHORE UNIV HEALTHSYSTEM RES INST · PI BACKMAN, VADIM, ROY, HEMANT K. · 2004 to 2015
$6.0M
Transforming Colorectal Cancer Screening through Multimodal Spectral MarkersR01CA156186 · NCI · ENDEAVOR HEALTH CLINICAL OPERATIONS · PI BACKMAN, VADIM, ROY, HEMANT K. · 2011 to 2015
$2.8M
Spectroscopy of blood supply changes in early precancerR01CA109861 · NCI · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM · 2005 to 2013
$1.7M
Improving colonoscopic miss rate by real time microvascular blood analysisR42CA130508 · NCI · AMERICAN BIOOPTICS, LLC · PI ROY, HEMANT K. · 2007 to 2009
$841k
Optically Monitoring Colon Microcirculation in PrecancerR01CA118794 · NCI · NORTHWESTERN UNIVERSITY · PI BACKMAN, VADIM · 2007 to 2009
$786k
Improving Flexible Sigmoidoscopy in Women by Optical Analysis of MicrovasculatureR21CA140936 · NCI · ENDEAVOR HEALTH CLINICAL OPERATIONS · PI BACKMAN, VADIM, ROY, HEMANT K. · 2009 to 2010
$382k
NCI NIH HHS 5R21CA140936NCI NIH HHS 5R42CA130508NCI NIH HHS R01 CA109861NCI NIH HHS R01CA109861NCI NIH HHS R01 CA118794NCI NIH HHS R01CA118794NCI NIH HHS R01 CA128641NCI NIH HHS R01CA128641NCI NIH HHS R01 CA156186NCI NIH HHS R01CA156186NCI NIH HHS R21 CA140936NCI NIH HHS R42 CA130508NCI NIH HHS U01 CA111257NCI NIH HHS U01CA111257
6 · The paper itself

Abstract

Spectroscopic techniques have demonstrated that in the microscopically normal mucosa, there is an increase in mucosal micro-circulation in patients harboring neoplasia elsewhere in the colon (i.e. marker of field carcinogenesis). However, the physiological and molecular basis of this early increase in blood supply (EIBS) has not been elucidated. We, therefore, investigated the microvessel density (MVD) and angiogenic gene expression in the premalignant colonic mucosa from the well-validated azoxymethane (AOM)-treated rat experimental model of colon carcinogenesis. Fisher 344 rats were treated with AOM (15 mg/kg i.p.) or saline and euthanized 14 weeks later (a time-point that precedes carcinoma development). Colon sections were studied for MVD via immunohistochemical assessment for CD31 and location was compared with optical assessment of mucosal hemoglobin with low-coherence enhanced backscattering spectroscopy (LEBS). Finally, we performed a pilot real-time PCR angiogenesis microarray (84 genes) from the microscopically normal colonic mucosa of AOM and age-matched saline treated rats. AOM treatment increased MVD in both the mucosa and submucosa of the rats (125% increase in mucosa; p<0.007, and 96% increase in submucosa; p<0.02) but the increase was most pronounced at the cryptal base consistent with the LEBS data showing maximal hemoglobin augmentation at 200-225 μm depth. Microarray analysis showed striking dysregulation of angiogenic and anti-angiogenic factors. We demonstrate, for the first time, that neo-angiogenesis occurs in the microscopically normal colonic mucosa and was accentuated at the bottom of the crypt. This finding has potential implications as a biomarker for risk-stratification and target for chemoprevention.

Indexed as

Neovascularization, PathologicAdenomaAnimalsAzoxymethaneBiomarkers, TumorBlotting, WesternCarcinogensCell Transformation, NeoplasticColonColonic NeoplasmsGene Expression ProfilingIntestinal MucosaOligonucleotide Array Sequence AnalysisRatsRats, Inbred F344Reverse Transcriptase Polymerase Chain ReactionAzoxymethaneBiomarkers, TumorCarcinogensRNA, Messenger

Identifiers

PMID21493000
PMCPMC3569093
OpenAlexW2091162444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.